MDS Guidance Framework for Electronic Clinical Outcome Assessments: Updating Practices for Validation and Implementation
Objective: To present the draft International Parkinson and Movement Disorder Society (MDS) guidance framework for validating, evaluating, and implementing electronic clinical outcome assessments (eCOAs). Background:…Retrospective Video-Based Motor Assessment: Feasibility and Inter-Rater Variability in Remote Scoring
Objective: To assess the feasibility of extracting video-derived motor biomarkers from retrospective clinical recordings in Parkinson's disease (PD) and quantify agreement with clinician-rated MDS-UPDRS Part III item…Clinical Stage According to Hoehn & Yahr Scale as a Predictor of Non-Motor Symptom Severity in Parkinson’s Disease: A Cross-Sectional in Peru
Objective: To determine the association between clinical stage of Parkinson's disease (PD), according to the Hoehn & Yahr (H&Y) scale, and the severity of non-motor…Implementation and Evaluation of a Pre-Clinic Questionnaire to Improve Data Capture and Consultation Efficiency in Parkinson’s Disease Clinics: A Multi-Centre Pilot Study
Objective: To evaluate the feasibility, usability, and clinical value of a pre-clinic questionnaire for patients attending Parkinson’s disease nurse specialist clinics. Background: Parkinson’s disease (PD)…Validation of an Objective Parkinson’s Disease Digital Assessment Tool in Individuals with PD and Healthy Controls
Objective: To validate the sensitivity and accuracy of a video-based motor assessment platform (PRIMS) against a panel of expert MDS-UPDRS reviewers. Background: The platform is…A Brief Clinical Test Battery Predicting UPDRS II Disability in Parkinson Disease
Objective: To determine whether a brief battery of commonly used clinical performance tests can predict disability in activities of daily living measured by UPDRS II…Performance of the functional staging of Parkinson’s disease using the Neuronal aSynuclein Disease Integrated Staging System (NSD-ISS) in the Critical Path for Parkinson’s (CPP) Integrated Parkinson’s Database
Objective: To evaluate the utility of the NSD-ISS for clinical staging of Parkinson’s disease (PD) by examining stage distribution, longitudinal stage transitions, and demographic predictors…Metabolic Syndrome is not Associated with Parkinson’s Disease Severity, but Individual Metabolic Components May Be
Objective: To investigate whether individual metabolic components are associated with motor, cognitive, and functional outcomes in Parkinson’s disease (PD). Background: Metabolic syndrome has been proposed…Are we overlooking wearing off? Evaluating the role of the WOQ-9 questionnaire in routine Parkinson’s care
Objective: 1. Evaluate clinicians’ ability to recognise wearing-off compared with the Wearing Off Questionnaire-9 (WOQ-9)2. Assess patient awareness of wearing-off symptoms Background: Wearing off is…Metabolic Syndrome and Disease Severity in Parkinson’s Disease: Association With Clinical Phenotype and Cerebral Small Vessel Disease
Objective: To evaluate the association between Parkinson’s disease (PD) severity (Hoehn & Yahr, H&Y; mild–moderate–severe) and metabolic syndrome (MetS) defined separately by NCEP-ATP III and…
- 1
- 2
- 3
- …
- 39
- Next Page »